Late-breaking data from the LIFE-BTK clinical trial showed that the Esprit BTK bioresorbable scaffold system offered better two-year outcomes than balloon angioplasty in severe peripheral artery disease (PAD) below the knee.

Palliative care is a recommended part of heart failure management in the U.S., but consultation rates remain low. The trend appears to impact Black patients more than other races and ethnicities. 

This marks a rare victory for the Biden administration and federal agencies seeking to uphold provisions of the No Surprises Act. 

Radiologists utilized the Apple Vision Pro to assess CT images of possible diverticulitis, comparing the results with a standard computer monitor. 

The Nashville-based multispecialty provider's CFO and CIO are both departing in January, with Envision launching a search to replace the latter. 

Following the Mediterranean diet, especially one rich with plant-based foods, could have significant benefits for cognitive health. 

A program dubbed the Clean Power Prescription sends half the energy generated by 519 solar panels on the hospital's roof back to patients, in the form of energy credits. 

Multiple late-breaking presentations at VIVA 2024 in Las Vegas focused on the benefits of treating peripheral artery disease with the company's intravascular lithotripsy portfolio.

Experts are hopeful that the portable scanner could improve access to neuroimaging used in the diagnosis and monitoring of Alzheimer's disease.

Philippe Genereux, MD, principal investigator of the EARLY TAVR trial, discussed how a proactive treatment strategy for patients with asymptomatic AS can lead to better outcomes and improvements in quality of life.